Rad AI Secures $8 Million Investment from Leading Health Systems

May 20, 2025
Rad AI has announced an additional $8 million investment from four major health systems, bringing its Series C funding to $68 million.

Rad AI has announced an additional $8 million strategic investment to its Series C funding round, led by four prominent health systems: Advocate Health, Memorial Hermann Health System, Corewell Health, and Atlantic Health System. This investment, announced in a press release, brings Rad AI's total Series C funding to $68 million.

These health systems are not only investors but also partners in advancing the application of generative AI across clinical environments. Rad AI's solutions, such as Rad AI Impressions and Rad AI Continuity, are designed to streamline radiology workflows and improve patient care by automating report generation and ensuring timely follow-up care.

The partnership aims to enhance care delivery for millions of patients by embedding AI into core workflows, thereby improving reporting efficiency and reducing radiologist burnout. The collaboration reflects a shared commitment to leveraging AI technology to address clinical and operational challenges in healthcare.

We hope you enjoyed this article

Free newsletter

AI Funding Brief

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.